Neutralizing antibodies have limited effects on the control of established HIV-1 infection in vivo
- PMID: 10229186
- DOI: 10.1016/s1074-7613(00)80043-6
Neutralizing antibodies have limited effects on the control of established HIV-1 infection in vivo
Abstract
Neutralizing antibodies can protect against challenge with HIV-1 in vivo if present at appropriate concentrations at the time of viral challenge, but any role in the control of established infection is unclear. Here, we show that high serum concentrations of neutralizing monoclonal antibodies, either singly or as a cocktail, have little sustained effect on viral load in established HIV-1 infection in hu-PBL-SCID mice. In some instances, virus replication of neutralization-sensitive virus continues even in the presence of high levels of neutralizing antibody. In most instances, neutralization escape occurs in a few days, even from a cocktail of three antibodies that recognize distinct epitopes. The results imply that humoral immunity is unlikely to play a significant role in the control of established HIV-1 infection in humans.
Similar articles
-
Neutralizing antibodies mechanism of neutralization and protective activity against HIV-1.Immunol Res. 2002;25(3):193-200. doi: 10.1385/IR:25:3:193. Immunol Res. 2002. PMID: 12018459 Review.
-
hu-PBL-SCID mice can be protected from HIV-1 infection by passive transfer of monoclonal antibody to the principal neutralizing determinant of envelope gp120.AIDS. 1993 Jan;7(1):15-21. doi: 10.1097/00002030-199301000-00002. AIDS. 1993. PMID: 7680205
-
Passive immunization with a human monoclonal antibody protects hu-PBL-SCID mice against challenge by primary isolates of HIV-1.Nat Med. 1997 Dec;3(12):1389-93. doi: 10.1038/nm1297-1389. Nat Med. 1997. PMID: 9396610
-
Resistance to human immunodeficiency virus 1 infection of SCID mice reconstituted with peripheral blood leukocytes from donors vaccinated with vaccinia gp160 and recombinant gp160.Proc Natl Acad Sci U S A. 1993 Mar 15;90(6):2443-7. doi: 10.1073/pnas.90.6.2443. Proc Natl Acad Sci U S A. 1993. PMID: 8460155 Free PMC article. Clinical Trial.
-
The role of neutralizing antibodies in HIV infection.AIDS Rev. 2006 Apr-Jun;8(2):51-9. AIDS Rev. 2006. PMID: 16848273 Review.
Cited by
-
HIV broadly neutralizing antibody targets.Curr Opin HIV AIDS. 2015 May;10(3):135-43. doi: 10.1097/COH.0000000000000153. Curr Opin HIV AIDS. 2015. PMID: 25760932 Free PMC article. Review.
-
Neutralizing antibodies mechanism of neutralization and protective activity against HIV-1.Immunol Res. 2002;25(3):193-200. doi: 10.1385/IR:25:3:193. Immunol Res. 2002. PMID: 12018459 Review.
-
The utilization of humanized mouse models for the study of human retroviral infections.Retrovirology. 2009 Aug 12;6:76. doi: 10.1186/1742-4690-6-76. Retrovirology. 2009. PMID: 19674458 Free PMC article. Review.
-
Viral persistence in vivo through selection of neutralizing antibody-escape variants.Proc Natl Acad Sci U S A. 2000 Mar 14;97(6):2749-54. doi: 10.1073/pnas.040558797. Proc Natl Acad Sci U S A. 2000. PMID: 10688894 Free PMC article.
-
Neutralizing antibodies do not mediate suppression of human immunodeficiency virus type 1 in elite suppressors or selection of plasma virus variants in patients on highly active antiretroviral therapy.J Virol. 2006 May;80(10):4758-70. doi: 10.1128/JVI.80.10.4758-4770.2006. J Virol. 2006. PMID: 16641269 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical